Olympus Partners has acquired PAI Pharma, a US-based manufacturer of generic oral liquids. No financial terms were disclosed. Kurt Orlofski serves as CEO of PAI. PAI Pharma has two large ...
STAMFORD, Conn., Feb. 11, 2025 /PRNewswire/ -- Olympus Partners was recognized for the second consecutive year as a Top 20 performer globally by the 2024 HEC Paris-DowJones Large Buyout ...
STAMFORD, Conn., Feb. 13, 2025 /PRNewswire/ -- Olympus Partners has acquired PAI Pharma ("PAI"), the leading developer, manufacturer and distributor of generic oral liquids in both ready-to-dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback